by Sue Brown, CEO ARMA
Last month the Government announced a new major conditions strategy. In the past ARMA’s response to such an announcement would be “what about MSK? That’s a major condition contributing hugely to the burden of disease in England.” Not this time.
I will admit to being surprised to read the list of six conditions included and find musculoskeletal disorders was one of them. Pleasantly surprised. Finally, in this one document at least, MSK seems to have parity with other conditions.…
Read more of this article
The NOA is excited to announce their third NOA Annual Members’ Conference taking place in Birmingham on Thursday 19 October 2023. Further information including registration details will be shared in due course.
With the year now in full flow, NRAS has been looking back at some of their achievements across 2022.
Ailsa’s presentation included:
Pain Concern is pleased to announce that the new edition of the Airing Pain podcast will be released on 22/02/2023:
After its success last year, the Primary Care Rheumatology and Musculoskeletal Medicine Society will be holding another revision course for the


In January 2023, NHS England published “an improvement framework to reduce community musculoskeletal waits while delivering best outcomes and experience”.
£1.94 million has been awarded by the Nuffield Foundation’s Oliver Bird Fund and Versus Arthritis to support research to improve wellbeing among people living with MSK conditions. Awards have been made to six teams across five universities.